Navigation Links
Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
Date:8/4/2008

PALO ALTO, Calif., Aug. 4 /PRNewswire/ -- Anacor Pharmaceuticals announced today that it has appointed Kurt Jarnagin, Ph.D., as its Vice President of Biological Research.

"We are pleased to welcome Kurt to the company," said Jacob Plattner, Ph.D., Senior Vice President of Research at Anacor Pharmaceuticals. "Kurt is a noted expert in the field of small molecule drugs involved in inflammation and his expertise will enrich our team as we continue to expand our pipeline fed by our boron chemistry platform."

Previously, Dr. Jarnagin was with Iconix Pharmaceuticals, Inc., serving as Vice President of Biology and Chemogenomics and Vice President of New Technology and Translational Medicine from 1998 to 2007. Dr. Jarnagin also held research leadership roles at Roche Pharmaceuticals (Palo Alto) from 1994 to 1998 and at Syntex Research, a specialty pharmaceutical company acquired by Roche, from 1986 to 1994.

At Iconix he directed the development of the DrugMatrix and ToxFX products -- tools and decision-making resources that aid scientists in the selection and prioritization of novel drugs. At Roche and Syntex he focused on drug discovery, targeting receptors and enzymes involved in inflammation, arthritis and asthma. Dr. Jarnagin was awarded the Fry-E. Werele International Kinin Chemistry Prize for work in the bradykinin field. He is the author of numerous peer-reviewed scientific papers and has several granted patents.

Dr. Jarnagin carried out highly cited studies of the insulin receptor at the Hormone Research Institute of the University of California, San Francisco. He received his Ph.D. in Biochemistry from the University of Wisconsin, Madison, and holds a B.S. in Biochemistry from North Carolina State University in Raleigh.

About Anacor Pharmaceuticals

Anacor is a biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform. Anacor has focused initially on developing to
'/>"/>

SOURCE Anacor Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Anacor to Present Clinical and Preclinical Data on Topical Anti-Inflammatory Candidates, AN2728 and AN2898, at the International Investigative Dermatology 2008 Conference
2. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
3. Anacor Files Registration Statement for Initial Public Offering
4. Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
5. VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress
6. Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
7. Poniard Pharmaceuticals to Present at the 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
8. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
9. Vista Partners Updates Coverage on Raptor Pharmaceuticals Corp. (OTC Bulletin Board: RPTP)
10. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
11. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Communications, a leading provider of strategic communications services to corporations and ... the United States and Europe ... JD, is returning to the firm,s Washington, D.C. ... more than two years of service as Associate Commissioner for the ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
(Date:1/14/2014)... and BETHESDA, Md. , ... joining together with two institutes from the National Institutes ... tools for bringing safer, more effective treatments to patients ... National Center for Advancing Translational Sciences (NCATS) and the ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... In Vitro and In Vivo Data Show AEZS-126 as ... CancerQUEBEC CITY, April 21 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. ... biopharmaceutical company focused on endocrine therapy and oncology, today ... clinical intervention of the PI3K/ Akt pathway in human ...
... HUBBARD, Ohio, April 21 NanoLogix, Inc. (OTC: NNLX) ... square foot manufacturing facility at its headquarters in Hubbard, ... vault, and shipping and receiving area to be used ... revolutionary new BNP(TM) kits provide accelerated detection of bacteria ...
... Data Selected for Presentation Highlights Anti-Tumor effects of ... Inc. (Nasdaq: KERX ) today announced ... effects of KRX-0401 (perifosine), the company,s lead anti-cancer ... (AACR) Annual Meeting, being held in Denver, Colorado. ...
Cached Biology Technology:AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting 2AEterna Zentaris Presents Two Posters on its PI3K Inhibitor Compound, AEZS-126, at AACR Annual Meeting 3NanoLogix Begins Construction of Production Facility for Medical Test Kits 2NanoLogix Begins Construction of Production Facility for Medical Test Kits 3Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research 2Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research 3Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research 4
(Date:4/22/2014)... new secret to get your child to behave at the ... new Cornell study published in Eating Behaviors , found ... to bite with their front teeth such as drumsticks, whole ... than when these foods had been cut. "They were ... toward other kids," said Brian Wansink, Professor and Director of ...
(Date:4/22/2014)... from the Florida campus of The Scripps Research Institute ... critical but previously unknown role in learning and memory ... role for a protein known as RGS7, was published ... a publisher supported by the Howard Hughes Medical Institute, ... "This is a critical building block that regulates a ...
(Date:4/22/2014)... Scientists at the University of Massachusetts Amherst and the ... week report that they have discovered a new genus ... the Negro River in the Amazonia State of Brazil. ... Adlia Nogueira and Jos Antnio Alves-Gomes of INPA, describe ... the journal Proceedings of the Natural Sciences of ...
Breaking Biology News(10 mins):Biting vs. chewing 2Scientists identify critical new protein complex involved in learning and memory 2New electric fish genus and species discovered in Brazil's Rio Negro 2
... Yang Wang is known for conducting complex research using highly ... spent days hiking through the remote outback of Tibet and ... the name of scientific discovery. Because of that unique ... a team of researchers that uncovered the oldest prehistoric woolly ...
... found in the oceans and belong to the group SAR11. ... an explanation for their success and at the same time ... their analysis they have also identified a rare and hitherto ... findings were published in two articles in the journals ...
... D.C. The American Association for Cancer Research will ... Cancer Health Disparities from Sept. 18-21, 2011, in the ... This conference will bring together scientists, survivors, doctors and ... epidemiology and treatment methods to better meet the needs ...
Cached Biology News:A wild and woolly discovery: FSU scientist's Tibetan expedition ends with prehistoric find 2A wild and woolly discovery: FSU scientist's Tibetan expedition ends with prehistoric find 3Unknown ocean bacteria create entirely new theories 2AACR to host conference on the science of cancer health disparities 2
...
... The Thermo Labsystems Wellmix is a high-quality ... time settings. The shaking speed is adjustable ... frequency, high speed and a small orbit ... The shaking time is quick and easy ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
... together two mature, well-understood technologies: grating-based ... This combination produces a sensitive and ... of molecular binding events without the ... capture molecules are immobilized on the ...
Biology Products: